Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Jupiter Fund Management chair announces his retirement

(Sharecast News) - Jupiter Fund Management announced on Thursday that David Cruickshank, chair of the board, intended to retire later this year. The FTSE 250 company said he would remain in post until a successor was appointed, but would not seek re-election at the 2026 annual general meeting.

Its board said it had initiated a formal search for a new chair, which would be led by senior independent director Suzy Neubert as part of the nomination committee's succession planning.

"It has been a privilege to act as chair for Jupiter, to lead the board, and to support Matt and his leadership team with the progress they have made towards our strategic objectives," said David Cruickshank.

Suzy Neubert, senior independent director, said that under Cruickshank's leadership, the company had made "significant strategic progress", adding that the board was focussed on appointing a successor who could continue to build on that momentum.

At 1119 BST, shares in Jupiter Fund Management were up 0.69% at 72.9p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.